Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cilomilast | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| measure of lung function and quality of life in patients with COPD |
| Measure | Description | Time Frame |
|---|---|---|
| exacerbations in patients with COPD |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35209 | United States | ||
| GSK Investigational Site |
Not provided
| Label | URL |
|---|---|
| Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research. | View source |
| ID | Type | URL | Comment |
|---|---|---|---|
| CIL103657 | Statistical Analysis Plan | View IPD |
Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jul 17, 2017 | |
| Reset | Dec 13, 2017 | |
| Release | Dec 20, 2017 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Jasper |
| Alabama |
| 35501 |
| United States |
| GSK Investigational Site | Phoenix | Arizona | 85006 | United States |
| GSK Investigational Site | Tempe | Arizona | 85282 | United States |
| GSK Investigational Site | Berkeley | California | 94705 | United States |
| GSK Investigational Site | Carmichael | California | 95608 | United States |
| GSK Investigational Site | Fullerton | California | 92835 | United States |
| GSK Investigational Site | Long Beach | California | 90806 | United States |
| GSK Investigational Site | Long Beach | California | 90822 | United States |
| GSK Investigational Site | Los Angeles | California | 90048 | United States |
| GSK Investigational Site | Murrieta | California | 92562 | United States |
| GSK Investigational Site | Rancho Mirage | California | 92270 | United States |
| GSK Investigational Site | Riverside | California | 92805 | United States |
| GSK Investigational Site | Sacramento | California | 95823 | United States |
| GSK Investigational Site | San Diego | California | 92103 | United States |
| GSK Investigational Site | San Diego | California | 92120 | United States |
| GSK Investigational Site | San Jose | California | 95117 | United States |
| GSK Investigational Site | Sepulveda | California | 91343 | United States |
| GSK Investigational Site | Stockton | California | 95207 | United States |
| GSK Investigational Site | Torrance | California | 90509 | United States |
| GSK Investigational Site | Vista | California | 92083 | United States |
| GSK Investigational Site | Walnut Creek | California | 94598 | United States |
| GSK Investigational Site | Boulder | Colorado | 80304 | United States |
| GSK Investigational Site | Colorado Springs | Colorado | 80907 | United States |
| GSK Investigational Site | Denver | Colorado | 80230 | United States |
| GSK Investigational Site | Englewood | Colorado | 80112 | United States |
| GSK Investigational Site | Fort Collins | Colorado | 80528 | United States |
| GSK Investigational Site | Wheat Ridge | Colorado | 80033 | United States |
| GSK Investigational Site | Hartford | Connecticut | 06105 | United States |
| GSK Investigational Site | Stamford | Connecticut | 06902 | United States |
| GSK Investigational Site | Waterbury | Connecticut | 06708 | United States |
| GSK Investigational Site | Aventura | Florida | 33180 | United States |
| GSK Investigational Site | Brandon | Florida | 33511 | United States |
| GSK Investigational Site | DeLand | Florida | 32720 | United States |
| GSK Investigational Site | Fort Lauderdale | Florida | 33316 | United States |
| GSK Investigational Site | Largo | Florida | 33770 | United States |
| GSK Investigational Site | Longwood | Florida | 32779 | United States |
| GSK Investigational Site | Melbourne | Florida | 32935 | United States |
| GSK Investigational Site | Panama City | Florida | 32405 | United States |
| GSK Investigational Site | Pensacola | Florida | 32504 | United States |
| GSK Investigational Site | Tamarac | Florida | 33321 | United States |
| GSK Investigational Site | Tampa | Florida | 33613 | United States |
| GSK Investigational Site | West Palm Beach | Florida | 33409 | United States |
| GSK Investigational Site | Atlanta | Georgia | 30342 | United States |
| GSK Investigational Site | Decatur | Georgia | 30033 | United States |
| GSK Investigational Site | Coeur d'Alene | Idaho | 83814 | United States |
| GSK Investigational Site | Normal | Illinois | 61761 | United States |
| GSK Investigational Site | Evansville | Indiana | 47710 | United States |
| GSK Investigational Site | South Bend | Indiana | 46617 | United States |
| GSK Investigational Site | Wichita | Kansas | 67207 | United States |
| GSK Investigational Site | Madisonville | Kentucky | 42431 | United States |
| GSK Investigational Site | Lafayette | Louisiana | 70503 | United States |
| GSK Investigational Site | New Orleans | Louisiana | 70119 | United States |
| GSK Investigational Site | Slidell | Louisiana | 70461 | United States |
| GSK Investigational Site | Sunset | Louisiana | 70584 | United States |
| GSK Investigational Site | Boston | Massachusetts | 02135 | United States |
| GSK Investigational Site | Cadillac | Michigan | 49601 | United States |
| GSK Investigational Site | Minneapolis | Minnesota | 55402 | United States |
| GSK Investigational Site | Jefferson City | Missouri | 65109 | United States |
| GSK Investigational Site | Saint Charles | Missouri | 63301 | United States |
| GSK Investigational Site | St Louis | Missouri | 63122 | United States |
| GSK Investigational Site | St Louis | Missouri | 63141 | United States |
| GSK Investigational Site | Billings | Montana | 59102 | United States |
| GSK Investigational Site | Missoula | Montana | 59808 | United States |
| GSK Investigational Site | Las Vegas | Nevada | 89104 | United States |
| GSK Investigational Site | Cherry Hill | New Jersey | 08003 | United States |
| GSK Investigational Site | Bronxville | New York | 10708 | United States |
| GSK Investigational Site | Cortland | New York | 14850 | United States |
| GSK Investigational Site | Larchmont | New York | 10538 | United States |
| GSK Investigational Site | New York | New York | 10016 | United States |
| GSK Investigational Site | Chapel Hill | North Carolina | 27599 | United States |
| GSK Investigational Site | Charlotte | North Carolina | 28207 | United States |
| GSK Investigational Site | Elizabeth City | North Carolina | 27909 | United States |
| GSK Investigational Site | High Point | North Carolina | 27262 | United States |
| GSK Investigational Site | Statesville | North Carolina | 28625 | United States |
| GSK Investigational Site | Chardon | Ohio | 44024 | United States |
| GSK Investigational Site | Columbus | Ohio | 43215 | United States |
| GSK Investigational Site | Dayton | Ohio | 45406 | United States |
| GSK Investigational Site | Sylvania | Ohio | 43560 | United States |
| GSK Investigational Site | Lake Oswego | Oregon | 97035 | United States |
| GSK Investigational Site | Medford | Oregon | 97504 | United States |
| GSK Investigational Site | Portland | Oregon | 97213 | United States |
| GSK Investigational Site | Allentown | Pennsylvania | 18103 | United States |
| GSK Investigational Site | Downington | Pennsylvania | 19335 | United States |
| GSK Investigational Site | Elverson | Pennsylvania | 19520 | United States |
| GSK Investigational Site | Erie | Pennsylvania | 16508 | United States |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15213 | United States |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15218 | United States |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15243 | United States |
| GSK Investigational Site | Swarthmore | Pennsylvania | 19081 | United States |
| GSK Investigational Site | East Providence | Rhode Island | 02914 | United States |
| GSK Investigational Site | Charleston | South Carolina | 29406-7108 | United States |
| GSK Investigational Site | Gaffney | South Carolina | 29340 | United States |
| GSK Investigational Site | Greer | South Carolina | 29651 | United States |
| GSK Investigational Site | Simpsonville | South Carolina | 29681 | United States |
| GSK Investigational Site | Spartanburg | South Carolina | 29303 | United States |
| GSK Investigational Site | Bristol | Tennessee | 37620 | United States |
| GSK Investigational Site | Chattanooga | Tennessee | 37403 | United States |
| GSK Investigational Site | Johnson City | Tennessee | 37601 | United States |
| GSK Investigational Site | Knoxville | Tennessee | 37920 | United States |
| GSK Investigational Site | Corsicana | Texas | 75110 | United States |
| GSK Investigational Site | Dallas | Texas | 75246 | United States |
| GSK Investigational Site | Fort Worth | Texas | 76104 | United States |
| GSK Investigational Site | San Antonio | Texas | 78205 | United States |
| GSK Investigational Site | San Antonio | Texas | 78217 | United States |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States |
| GSK Investigational Site | Salt Lake City | Utah | 84102 | United States |
| GSK Investigational Site | Richmond | Virginia | 23225 | United States |
| GSK Investigational Site | Richmond | Virginia | 23229 | United States |
| GSK Investigational Site | Bellingham | Washington | 98225 | United States |
| GSK Investigational Site | Spokane | Washington | 99204 | United States |
| GSK Investigational Site | Spokane | Washington | 99207 | United States |
| GSK Investigational Site | Tacoma | Washington | 98405 | United States |
| GSK Investigational Site | Morgantown | West Virginia | 26505 | United States |
| GSK Investigational Site | Milwaukee | Wisconsin | 53209-0996 | United States |
For additional information about this study please refer to the GSK Clinical Study Register |
| CIL103657 | Study Protocol | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| CIL103657 | Clinical Study Report | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| CIL103657 | Informed Consent Form | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| CIL103657 | Individual Participant Data Set | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| CIL103657 | Dataset Specification | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| Unrelease | Aug 15, 2018 |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 17, 2017 | Dec 13, 2017 | |||
| Dec 20, 2017 | Aug 15, 2018 |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| C433247 | Cilomilast |
Not provided
Not provided
Not provided